Nonne-Milroy-Meige Syndrome – Causes and Treatment
Nonne-Milroy-Meige syndrome is a rare hereditary disorder of the lymphatic system that causes chronic lymphedema, primarily affecting the extremities.
Things worth knowing about "Nonne-Milroy-Meige Syndrome"
Nonne-Milroy-Meige syndrome is a rare hereditary disorder of the lymphatic system that causes chronic lymphedema, primarily affecting the extremities.
What is Nonne-Milroy-Meige Syndrome?
Nonne-Milroy-Meige syndrome refers to a group of hereditary lymphedemas caused by developmental or functional abnormalities of the lymphatic vessel system. It is a rare condition belonging to the category of primary lymphedemas. The syndrome is named after the physicians Max Nonne, William Milroy, and Henri Meige, who were among the first to describe these clinical presentations.
Depending on the age of onset, the syndrome is divided into congenital lymphedema (Milroy disease, present at birth or shortly after) and lymphedema praecox (Meige disease, appearing during puberty or early adulthood).
Causes
The condition is caused by genetic mutations that impair the development and function of lymphatic vessels. In the Milroy form (congenital lymphedema), mutations in the FLT4 gene are frequently identified. This gene encodes vascular endothelial growth factor receptor 3 (VEGFR-3), which plays a critical role in lymphatic vessel growth and maturation.
- Autosomal dominant inheritance pattern (in many cases)
- Mutations in the FLT4 gene (Milroy form)
- Genetic heterogeneity: various genes may be involved
- Spontaneous de novo mutations are also possible
Symptoms
The hallmark symptom of Nonne-Milroy-Meige syndrome is chronic lymphedema -- a painless, doughy swelling of the affected tissue caused by an accumulation of lymphatic fluid. The lower extremities are most commonly affected, with the upper extremities or other body regions involved less frequently.
- Chronic, painless swelling of the legs and/or arms
- Swelling is typically symmetrical
- Progressive skin hardening and thickening (fibrosis) over time
- Restricted mobility of affected limbs
- Increased risk of recurrent skin infections (erysipelas)
- Psychosocial impact due to altered physical appearance
Diagnosis
Diagnosis is primarily clinical and is confirmed through additional investigations. A thorough medical history, including a detailed family history, is essential given the rarity of the condition.
- Clinical examination: Assessment of swelling, tissue consistency, and distribution of edema
- Lymphoscintigraphy: Imaging to evaluate lymphatic vessel function and morphology
- MRI or ultrasound: Assessment of soft tissue changes
- Genetic testing: Detection of mutations (e.g., in the FLT4 gene)
- Differential diagnosis: Exclusion of secondary lymphedema (e.g., due to infection or malignancy)
Treatment
There is currently no curative treatment for Nonne-Milroy-Meige syndrome. Therapy aims to reduce lymphedema, improve quality of life, and prevent complications. Complete decongestive therapy (CDT) is considered the gold standard of treatment.
Conservative Treatment
- Manual lymphatic drainage performed by trained therapists
- Compression therapy (medical compression stockings or bandages)
- Decongestive exercise therapy and physiotherapy
- Skin care to prevent infections
Surgical Treatment
- Microsurgical lymphatic anastomoses (connecting lymphatic and venous channels)
- Lymph node transplantation in selected cases
- Reduction surgery in cases of severe tissue overgrowth
Pharmacological Treatment
There is no specifically approved pharmacological therapy. Antibiotics are used in cases of infection (erysipelas). Experimental approaches involving VEGF-C or other growth factors are currently under investigation.
Prognosis and Disease Course
Nonne-Milroy-Meige syndrome is a chronic, lifelong condition. However, with consistent treatment, swelling can be significantly reduced and quality of life substantially improved. Without treatment, there is a risk of progressive tissue fibrosis and recurrent infections.
References
- Rockson SG. Lymphedema. Am J Med. 2001;110(4):288-295.
- Connell FC et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an updated proposal from the International Society of Lymphology. Lymphology. 2013;46(2):62-68.
- Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest. 2014;124(3):915-921.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Portion control
Food craving
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Nonne-Milroy-Meige Syndrome-en